Synagis

Showing 2 posts of 2 posts found.

shutterstock_273326141

AstraZeneca sells off paediatric lung infection drug to Sobi for $1.5bn

November 13, 2018
Manufacturing and Production, Sales and Marketing AstraZeneca, Synagis, espiratory syncytial virus, pharma, sobi

AstraZeneca has jettisoned another non-essential asset with the sale of Synagis (palivizumab), a preventative treatment for infections relating to respiratory …

AZ accepts $92.5m to settle respiratory dispute

February 18, 2011
Sales and Marketing AZ, AstraZeneca, MedImmune, PDL BioPharma, Synagis, patent dispute, respiratory

AstraZeneca’s MedImmune subsidiary is to receive $92.5 million as part of a legal settlement involving its respiratory drug Synagis. PDL …

The Gateway to Local Adoption Series

Latest content